{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:22:03Z","timestamp":1791505323292,"version":"4.3.4"},"reference-count":125,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.anai.2020.11.016","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T14:16:52Z","timestamp":1606832212000},"page":"240-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The spectrum of allergic ocular diseases"],"prefix":"10.1016","volume":"126","author":[{"given":"Jonathan","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merin E.","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Vanijcharoenkarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton M.","family":"Hom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana V.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/09595287190100P111","article-title":"Case of a periodical affection of the eyes and chest","volume":"10","author":"Bostock","year":"1819","journal-title":"Med Chir Trans"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000093076","article-title":"The differential diagnosis of red eye: a survey of medical practitioners from Eastern Europe and the Middle East","volume":"220","author":"Petricek","year":"2006","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1939-4551-6-4","article-title":"Recognition of allergic conjunctivitis in patients with allergic rhinitis","volume":"6","author":"Williams","year":"2013","journal-title":"World Allergy Organ J"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States, 1988-1994","volume":"126","author":"Singh","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2015.11.006","article-title":"Asthma, oculonasal symptoms, and skin test sensitivity across National Health and Nutrition Examination Surveys","volume":"116","author":"Meng","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2500\/aap.2014.35.3750","article-title":"Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and rhinoconjunctivitis (AIRS) surveys","volume":"35","author":"Bielory","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4168\/aair.2015.7.1.44","article-title":"The burden of rhinitis and rhinoconjunctivitis in adolescents","volume":"7","author":"Cibella","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"issue":"11","key":"10.1016\/j.anai.2020.11.016_bib10","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/all.12009","article-title":"Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface","volume":"67","author":"Leonardi","year":"2012","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pai.12197","article-title":"Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes","volume":"25","author":"Vichyanond","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib12","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.5415\/apallergy.2018.8.e7","article-title":"The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions","volume":"8","author":"Passali","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.anai.2020.11.016_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/OPTH.S129552","article-title":"Vernal keratoconjunctivitis","volume":"12","author":"Addis","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13052-019-0656-4","article-title":"Vernal keratoconjunctivitis: an update focused on clinical grading system","volume":"45","author":"Zicari","year":"2019","journal-title":"Ital J Pediatr"},{"issue":"8","key":"10.1016\/j.anai.2020.11.016_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bjo.2007.117812","article-title":"Prevalence of vernal keratoconjunctivitis: a rare disease?","volume":"92","author":"Bremond-Gignac","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaad.2013.10.036","article-title":"Atopic keratoconjunctivitis: a review","volume":"70","author":"Chen","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.anai.2020.11.016_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1590\/S0004-27492009000600012","article-title":"Atopic keratoconjunctivitis in patients of the pediatric dermatology ambulatory in a reference center","volume":"72","author":"Moscovici","year":"2009","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.iac.2010.06.004","article-title":"Atopic dermatitis and keratoconjunctivitis","volume":"30","author":"Bielory","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0161-6420(91)32322-4","article-title":"Clinical features of atopic keratoconjunctivitis","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/ACI.0b013e32833e16e4","article-title":"Atopic keratoconjunctivitis and atopic dermatitis","volume":"10","author":"Guglielmetti","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2020.11.016_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/ICU.0000000000000532","article-title":"Ocular involvement in atopic disease: a review","volume":"29","author":"Patel","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11882-012-0252-9","article-title":"Diagnostics and new developments in the treatment of ocular allergies","volume":"12","author":"Kari","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00018-011-0846-8","article-title":"Allergic contact dermatitis: epidemiology, molecular mechanisms, in\u00a0vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany","volume":"69","author":"Peiser","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2310\/6620.2007.06041","article-title":"Common contact allergens associated with eyelid dermatitis: data from the North American Contact Dermatitis Group 2003-2004 study period","volume":"18","author":"Rietschel","year":"2007","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2009.06.012","article-title":"Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis","volume":"124","author":"Fukuda","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2222.1996.tb00059.x","article-title":"Detection of allergen-specific IgE in tears of grass pollen-allergic patients with allergic rhinoconjunctivitis","volume":"26","author":"Hoffmann-Sommergruber","year":"1996","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jtos.2013.10.007","article-title":"The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation","volume":"12","author":"Saban","year":"2014","journal-title":"Ocul Surf"},{"key":"10.1016\/j.anai.2020.11.016_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.07.019","article-title":"Allergy and allergic mediators in tears","volume":"117","author":"Leonardi","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.anai.2020.11.016_bib29","first-page":"1453","article-title":"Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa","volume":"19","author":"Pelikan","year":"2013","journal-title":"Mol Vis"},{"issue":"9","key":"10.1016\/j.anai.2020.11.016_bib30","first-page":"1242","article-title":"Serum levels of IL-17 in patients with vernal keratoconjunctivitis: a preliminary report","volume":"17","author":"Zicari","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.anai.2020.11.016_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bjo.82.7.797","article-title":"Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis","volume":"82","author":"Yokoi","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib32","doi-asserted-by":"crossref","first-page":"12162","DOI":"10.1038\/s41598-018-30002-x","article-title":"Context-dependent regulation of conjunctival goblet cell function by allergic mediators","volume":"8","author":"Garcia-Posadas","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.anai.2020.11.016_bib33","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1398-9995.2008.01781.x","article-title":"Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis","volume":"63","author":"Dogru","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaci.2015.11.039","article-title":"The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases","volume":"138","author":"Fujishima","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","article-title":"Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities","volume":"7","author":"Leonardi","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","article-title":"Allergic conjunctivitis and dry eye syndrome","volume":"108","author":"Hom","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/OPX.0b013e31815ed756","article-title":"Superficial punctate fluorescein staining of the ocular surface","volume":"85","author":"Ward","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib38","doi-asserted-by":"crossref","first-page":"AB272","DOI":"10.1016\/j.jaci.2014.12.1830","article-title":"Ocular papillary changes on the caruncle surface in allergic conjunctivitis","volume":"135","author":"Hom","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00006324-199003000-00008","article-title":"Association of giant papillary conjunctivitis with seasonal allergies","volume":"67","author":"Begley","year":"1990","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.anai.2020.11.016_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older","volume":"182","author":"Farrand","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib44","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/ACI.0b013e3283306990","article-title":"Allergy to ophthalmic preservatives","volume":"9","author":"Hong","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10086","key":"10.1016\/j.anai.2020.11.016_bib46","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.anai.2020.11.016_bib48","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMc1700366","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"376","author":"Simpson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib49","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jaip.2018.01.034","article-title":"Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment","volume":"6","author":"Wollenberg","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2020.11.016_bib50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jamadermatol.2019.0209","article-title":"Learning about dupilumab-associated conjunctivitis-reply","volume":"155","author":"Treister","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.anai.2020.11.016_bib51","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/jdv.15608","article-title":"Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy - international eczema council survey and opinion","volume":"33","author":"Thyssen","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.17538","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40268-019-00288-x","article-title":"A\u00a0clinician\u2019s guide to the recognition and management of dupilumab-associated conjunctivitis","volume":"19","author":"Agnihotri","year":"2019","journal-title":"Drugs R D"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40123-019-0191-9","article-title":"Ocular surface diseases induced by dupilumab in severe atopic dermatitis","volume":"8","author":"Maudinet","year":"2019","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib55","first-page":"488","article-title":"Management of dupilumab-associated conjunctivitis in atopic dermatitis","volume":"17","author":"Aszodi","year":"2019","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"10","key":"10.1016\/j.anai.2020.11.016_bib56","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.13178","article-title":"Diagnostic tools in ocular allergy","volume":"72","author":"Leonardi","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib57","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-7022-1-2","article-title":"Diagnostic tools in Rhinology EAACI position paper","volume":"1","author":"Scadding","year":"2011","journal-title":"Clin Transl Allergy"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/ACI.0000000000000563","article-title":"Office-based ocular procedures for the allergist","volume":"19","author":"Leonardi","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.anai.2020.11.016_bib59","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3109\/02713683.2012.689069","article-title":"Relation between total tear IgE and severity of acute seasonal allergic conjunctivitis","volume":"37","author":"Mimura","year":"2012","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib60","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/eye.1998.68","article-title":"Tear IgE concentrations in allergic conjunctivitis","volume":"12","author":"Nomura","year":"1998","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/all.12986","article-title":"Conjunctival allergen provocation test: guidelines for daily practice","volume":"72","author":"Fauquert","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2020.11.016_bib62","series-title":"Middleton\u2019s Allergy: Principles and Practice","author":"Adkinson","year":"2013"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.alit.2016.12.004","article-title":"Japanese guidelines for allergic conjunctival diseases 2017","volume":"66","author":"Takamura","year":"2017","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/eye.1993.93","article-title":"Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin tests, and conjunctival and nasal provocation tests in patients with ocular allergic disease","volume":"7","author":"Leonardi","year":"1993","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib65","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60453-X","article-title":"Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate","volume":"100","author":"Bielory","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib66","first-page":"537","article-title":"Relationship between TOSS questionnaire and two dry eye questionnaires (OSDI and SEsoD)","volume":"53","author":"Bielory","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2007.06.028","article-title":"Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire","volume":"144","author":"Sacchetti","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"suppl 5","key":"10.1016\/j.anai.2020.11.016_bib68","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib69","doi-asserted-by":"crossref","first-page":"P94","DOI":"10.1016\/j.ophtha.2018.10.020","article-title":"Conjunctivitis preferred practice pattern \u00ae","volume":"126","author":"Varu","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2500\/aap.2013.34.3695","article-title":"An algorithm for the management of allergic conjunctivitis","volume":"34","author":"Bielory","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11882-019-0844-8","article-title":"Emerging therapeutics for ocular surface disease","volume":"19","author":"Bielory","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/ACI.0000000000000392","article-title":"Ocular surface lubricants","volume":"17","author":"Bielory","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.anai.2020.11.016_bib73","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy","volume":"74","author":"Leonardi","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2500\/aap.2017.38.4003","article-title":"Diagnosis and management of allergic conjunctivitis in pediatric patients","volume":"38","author":"Berger","year":"2017","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib75","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ACI.0000000000000473","article-title":"Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends","volume":"18","author":"Ben-Eli","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2500\/ar.2016.7.0158","article-title":"Treating allergic conjunctivitis: a once-daily medication that provides 24-hour symptom relief","volume":"7","author":"Carr","year":"2016","journal-title":"Allergy Rhinol (Providence)"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib77","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1034\/j.1398-9995.2003.00081.x","article-title":"Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases","volume":"58","author":"Woerly","year":"2003","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2500\/108854191778879313","article-title":"The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis","volume":"12","author":"Nabe","year":"1991","journal-title":"Allergy Proc"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":"Topical azelastine in perennial allergic conjunctivitis","volume":"19","author":"Canonica","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2020.11.016_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1824-7288-39-18","article-title":"Allergic conjunctivitis: a comprehensive review of the literature","volume":"39","author":"La Rosa","year":"2013","journal-title":"Ital J Pediatr"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib81","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-200565020-00004","article-title":"Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis","volume":"65","author":"Bielory","year":"2005","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib82","first-page":"287","article-title":"Systemic reactions to ophthalmic drug preparations","volume":"2","author":"Fraunfelder","year":"1987","journal-title":"Med Toxicol Adverse Drug Exp"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11882-011-0188-5","article-title":"Antihistamines in ocular allergy: are they all created equal?","volume":"11","author":"Abelson","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2020.11.016_bib85","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2147\/OPTH.S185835","article-title":"Phase III trials examining the efficacy of cetirizine ophthalmic solution 0.24% compared to vehicle for the treatment of allergic conjunctivitis in the conjunctival allergen challenge model","volume":"12","author":"Meier","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.anai.2020.11.016_bib86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/OPTH.S186092","article-title":"Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects","volume":"13","author":"Malhotra","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaip.2012.07.001","article-title":"Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis","volume":"1","author":"Gane","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib89","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/ACI.0b013e328357d3ba","article-title":"Ophthalmic antihistamines and H1-H4 receptors","volume":"12","author":"Wade","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2020.11.016_bib90","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/JAA.S160687","article-title":"Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis","volume":"11","author":"Cavet","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICL.0b013e318193a3df","article-title":"Epinastine 0.05% ophthalmic solution in contact lens-wearing subjects with a history of allergic conjunctivitis","volume":"35","author":"Nichols","year":"2009","journal-title":"Eye Contact Lens"},{"issue":"suppl","key":"10.1016\/j.anai.2020.11.016_bib92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0039-6257(93)90038-9","article-title":"Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis","volume":"38","author":"Ballas","year":"1993","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ICL.0000092071.82938.46","article-title":"Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis","volume":"30","author":"Ilyas","year":"2004","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib94","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","article-title":"Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"87","author":"Borazan","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/ACI.0b013e32833dfa28","article-title":"Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis","volume":"10","author":"Bielory","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2020.11.016_bib96","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1185\/03007995.2015.1058250","article-title":"Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis","volume":"31","author":"Wu","year":"2015","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib97","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2500\/aap.2011.32.3420","article-title":"Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: a systematic review","volume":"32","author":"Hong","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/IJG.0000000000001164","article-title":"The relationship between long-term use of intranasal corticosteroid and intraocular pressure","volume":"28","author":"Mohd Zain","year":"2019","journal-title":"J\u00a0Glaucoma"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib99","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/lary.27209","article-title":"Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis","volume":"129","author":"Valenzuela","year":"2019","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib100","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2011.07.004","article-title":"Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study","volume":"128","author":"Lambiase","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib101","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2003.10.065","article-title":"Vernal keratoconjunctivitis: result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment","volume":"113","author":"Vichyanond","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2020.11.016_bib102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/02713680802149115","article-title":"Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study","volume":"33","author":"Attas-Fox","year":"2008","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib103","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/09546630903401470","article-title":"Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials","volume":"21","author":"Chen","year":"2010","journal-title":"J\u00a0Dermatol Treat"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib104","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/112067211002000506","article-title":"Systemic cyclosporin A in severe atopic keratoconjunctivitis","volume":"20","author":"Cornish","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.anai.2020.11.016_bib105","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","article-title":"Systemic cyclosporine A in severe atopic keratoconjunctivitis","volume":"104","author":"Hoang-Xuan","year":"1997","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.anai.2020.11.016_bib106","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.anai.2020.11.016_bib107","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic innoculation against hay fever","volume":"4","author":"Noon","year":"1911","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.anai.2020.11.016_bib108","first-page":"CD007685","article-title":"Sublingual immunotherapy for treating allergic conjunctivitis","volume":"7","author":"Calderon","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.anai.2020.11.016_bib109","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1398-9995.2009.02238.x","article-title":"Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life","volume":"65","author":"Frolund","year":"2010","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.anai.2020.11.016_bib110","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00417-019-04389-w","article-title":"One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis","volume":"257","author":"Sayed","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib111","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5935\/0004-2749.20170045","article-title":"Supratarsal injection of triamcinolone for severe vernal keratoconjunctivitis in children","volume":"80","author":"Costa","year":"2017","journal-title":"Arq Bras Oftalmol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib112","first-page":"241","article-title":"Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis","volume":"49","author":"Singh","year":"2001","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","article-title":"Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis","volume":"121","author":"Holsclaw","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib114","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/IOP.0000000000001315","article-title":"Bicanalicular silicone intubation for the management of punctal stenosis and obstruction in patients with allergic conjunctivitis","volume":"35","author":"Alsulaiman","year":"2019","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1442-9071.1998.tb01315.x","article-title":"Lacrimal canalicular obstruction associated with topical ocular medication","volume":"26","author":"McNab","year":"1998","journal-title":"Aust N Z J Ophthalmol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib116","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/01676830.2018.1518465","article-title":"Mini-monoka stenting for patients with perennial allergic conjunctivitis","volume":"38","author":"Or","year":"2019","journal-title":"Orbit"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib117","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jtos.2018.12.002","article-title":"Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis","volume":"17","author":"Jabbehdari","year":"2019","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.anai.2020.11.016_bib118","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ICO.0000000000001911","article-title":"Management of ocular allergy itch with an antihistamine-releasing contact lens","volume":"38","author":"Pall","year":"2019","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210362","article-title":"In\u00a0vitro and in\u00a0vivo performance of epinastine hydrochloride-releasing contact lenses","volume":"14","author":"Minami","year":"2019","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.anai.2020.11.016_bib120","first-page":"305","article-title":"Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab","volume":"17","author":"de Klerk","year":"2013","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.anai.2020.11.016_bib121","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2010.2919","article-title":"Omalizumab for severe atopic keratoconjunctivitis","volume":"2010","author":"Taille","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.anai.2018.09.458","article-title":"Omalizumab as single-dose therapy for vernal keratoconjunctivitis","volume":"122","author":"Simpson","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.anai.2020.11.016_bib123","doi-asserted-by":"crossref","first-page":"192","DOI":"10.29262\/ram.v65i2.292","article-title":"Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis","volume":"65","author":"Santamaria","year":"2018","journal-title":"Rev Alerg Mex"},{"issue":"5","key":"10.1016\/j.anai.2020.11.016_bib124","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/pai.12737","article-title":"Vernal keratoconjunctivitis treated with omalizumab: a case series","volume":"28","author":"Occasi","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.11.016_bib125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaophthalmol.2015.5679","article-title":"Omalizumab treatment of vernal keratoconjunctivitis","volume":"134","author":"Heffler","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.anai.2020.11.016_bib126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-016-0074-2","article-title":"Omalizumab in severe refractory vernal keratoconjunctivitis in children: case series and review of the literature","volume":"6","author":"Doan","year":"2017","journal-title":"Ophthalmol Ther"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:25:23Z","timestamp":1761053123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120620312205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1081120620312205"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2020.11.016","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of allergic ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2020.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}